Studies with genetic approaches including antisense oligonucleotides and RNA interference (RNAi) have demonstrated that inhibition of ERK1/2 signaling suppresses tumor growth and induces apoptosis in vitro and in vivo (26–28). Here, MAPK3 is linked to neoplasm.